Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation

NCT01653418 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Due to the high rate of morbidity and mortality

Conditions

Multiple Myeloma

Interventions

DRUG: Bortezomib
DRUG: Carmustine
DRUG: Etoposide
DRUG: Cytarabine
DRUG: Melphalan
PROCEDURE: Stem cell infusion

Sponsor

Washington University School of Medicine